Preparation method of cresoltrazol trisiloxane

By using the organophosphorus ligand Xantphos and a cobalt catalyst, the problems of high cost and decreased activity of platinum-based catalysts in the preparation of cresoltrazol trisiloxane have been solved, achieving high yield and high purity, reducing production costs and improving product quality.

CN123106734APending Publication Date: 2026-11-17CHANGZHOU YONGHE FINE CHEM
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202611204487.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-08-10
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

In existing methods for preparing cresoltrazol trisiloxane, platinum-based homogeneous catalysts are expensive and difficult to recycle, resulting in high production costs and environmental risks. Furthermore, benzotriazole UV absorber molecules are prone to poisoning the catalytic active center, affecting product quality.

Method used

A catalytic system using organophosphorus ligand Xantphos and a cobalt catalyst was employed to prepare cresoltrazol trisiloxane via hydrosilylation, avoiding the use of platinum-based catalysts. The system utilized sterically hindered chelating ligands to isolate the poisoning effect of phenolic hydroxyl groups and triazole heterocycles on the cobalt active center.

Benefits of technology

This study achieved the preparation of cresoltrazol trisiloxane with high yield and high purity, reduced catalytic costs, stabilized the activity of cobalt catalysts, and improved product quality.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

This invention discloses a method for preparing cresoltrazol trisiloxane, which is obtained by hydrosilylation reaction of 2-(2'-hydroxy-3'-methylallyl-5'-methylphenyl)benzotriazole and heptamethyltrisiloxane. The hydrosilylation reaction is carried out in the presence of an organophosphorus ligand and a cobalt catalyst. The organophosphorus ligand is 4,5-bis(diphenylphosphine-9,9-dimethyloxanthracene; the cobalt catalyst is one of cobalt chloride, cobalt bromide, and cobalt acetylacetonate. This invention uses an organophosphorus ligand and a cobalt catalyst as the catalytic system. This catalytic system, through the steric shielding effect of the sterically hindered chelating ligand of the organophosphorus ligand, can effectively isolate the poisoning effect of the phenolic hydroxyl group and triazole heterocycle in allylbenzotriazole on the cobalt active center, stabilizing the activity of the cobalt catalyst, thereby enabling highly selective anti-Markovnikov hydrosilylation reaction of allylbenzotriazole and heptamethyltrisiloxane.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the field of ultraviolet absorber preparation technology, specifically relating to a method for preparing cresoltrazol trisiloxane. Background Technology

[0002] Although traditional small-molecule 2-(2-hydroxyphenyl)benzotriazole UV absorbers have excellent UV absorption performance, their low molecular weight has obvious defects when used in sunscreen cosmetics: (1) small molecules are prone to skin penetration, which brings safety risks; (2) they are prone to crystallization in oil phase systems, which destroys the stability of the formula; (3) they have poor compatibility with silicone-based cosmetic raw materials, which can easily cause a heavy and sticky feeling on the skin.

[0003] By covalently grafting benzotriazole groups onto siloxane segments, the resulting siloxane-bonded UV absorber, cresoltrazol trisiloxane [CAS 155633-54-8], can simultaneously address the aforementioned pain points and represents an important development direction for high-end sunscreen raw materials.

[0004] The existing methods for preparing cresoltrazol trisiloxane are basically all based on the hydrosilylation reaction of 2-(2'-hydroxy-3'-methylallyl-5'-methylphenyl)benzotriazole [hereinafter referred to as allylbenzotriazole] and heptamethyltrisiloxane. Currently, this addition reaction relies entirely on platinum-based homogeneous catalysts such as those by Speier and Karstedt [see references CN120623220A, CN120757511A, CN121537427A, etc.]. Although platinum-based homogeneous catalysts have high reactivity and excellent anti-Markovnikov selectivity, However, there are inherent industry bottlenecks: (1) Platinum is a scarce precious metal, the raw material price is high, the catalyst cannot be recycled, and the product will also have residual heavy metal platinum, which greatly increases the production cost and the environmental risk of the product; (2) Benzotriazole UV absorber molecules contain phenolic hydroxyl groups and nitrogen-containing heterocyclic strong coordination functional groups, which are very easy to poison the platinum active center, causing a decrease in catalytic activity, thus requiring an increase in the amount of platinum used. This not only further increases the cost, but also leads to problems such as darkening of product color and increase in side reactions, which seriously restricts the industrial quality improvement of high-end transparent organosilicon light stabilizers. Summary of the Invention

[0005] The purpose of this invention is to solve the above-mentioned problems and provide a method for preparing cresoltrazol trisiloxane that not only has high reaction yield and product purity, but also low catalytic system cost.

[0006] The technical solution to achieve the objective of this invention is: a method for preparing cresoltrazol trisiloxane, which is obtained by hydrosilylation reaction of 2-(2'-hydroxy-3'-methylallyl-5'-methylphenyl)benzotriazole [hereinafter referred to as allylbenzotriazole] and heptamethyltrisiloxane; the hydrosilylation reaction is carried out in the presence of an organophosphorus ligand and a cobalt catalyst.

[0007] The organophosphine ligand is 4,5-bis(diphenylphosphine)-9,9-dimethyloxanthracene (Xantphos).

[0008] The cobalt catalyst is one of cobalt chloride, cobalt bromide, and cobalt acetylacetonate, preferably cobalt chloride.

[0009] The weight ratio of the organophosphine ligand to the cobalt catalyst is 10:1 to 2:1, preferably 6:1 to 3:1.

[0010] The total amount of the organophosphine ligand and the cobalt catalyst is 0.1-10% of the weight of the allylbenzotriazole, preferably 0.5-2%, and more preferably 1%.

[0011] The molar ratio of allylbenzotriazole to heptamethyltrisiloxane is 1:1 to 1:3, preferably 1:1.1 to 1:1.5. A larger amount of heptamethyltrisiloxane (>1.5) will not only increase costs but also lead to a lower yield. A smaller amount of heptamethyltrisiloxane (<1.1) will result in incomplete reaction of allylbenzotriazole and difficulty in removing residual allylbenzotriazole. Considering both economy and production efficiency, a molar ratio of 1.1 is preferred.

[0012] The hydrosilylation reaction temperature is 40–100°C, preferably 60°C.

[0013] The positive effects of this invention are as follows: This invention uses an organophosphorus ligand + cobalt catalyst as a catalytic system. This catalytic system can effectively isolate the poisoning effect of the phenolic hydroxyl group and triazole heterocycle in allylbenzotriazole on the cobalt active center through the steric shielding effect of the sterically hindered chelating ligand of the organophosphorus ligand, stabilize the activity of the cobalt catalyst, and thus efficiently catalyze the highly selective anti-Markovnikov hydrosilylation reaction between allylbenzotriazole and heptamethyltrisiloxane. Detailed Implementation

[0014] (Example 1) The specific preparation method of cresoltrazol trisiloxane in this embodiment is as follows: Add 1000 ml toluene, 280 g allylbenzotriazole (1 mol), 245 g heptamethyltrisiloxane (1.1 mol), 2.3 g organophosphorus ligand Xantphos, and 0.5 g cobalt catalyst cobalt chloride to a 1 L four-necked flask. Purge with nitrogen, stir, heat to 60 °C, and maintain the temperature for 18 h. Take a sample and test for allylbenzotriazole ≤1%, then stop the reaction.

[0015] After the reaction was completed, the temperature was lowered to 20℃, 20g of activated carbon was added for decolorization, the mixture was stirred, filtered, the organic phase was concentrated under reduced pressure, dried, and then 1000ml of ethanol was added and the mixture was heated to reflux to dissolve the solids. The mixture was then cooled to crystallize, a small amount of seed crystals was added at 45℃, the temperature was lowered to 5℃, the mixture was filtered, washed with 100ml of ethanol, dried under vacuum, and then dried in an oven to obtain 458.7g of cresoltrazol trisiloxane, with a yield of 91.2% and an HPLC purity of 99.6%.

[0016] (Examples 2 to 5) The preparation methods of each embodiment are basically the same as those of Example 1, and the differences are shown in Table 1.

[0017] Table 1 Example 1 Example 2 Example 3 Example 4 Example 5 heptamethyltrisiloxane 1.1mol 1.1mol 1.1mol 1.5mol 2.0 mol Xantphos 2.3g 2.4g 2.1g 2.3g 2.3g cobalt chloride 0.5g 0.4g 0.7g 0.5g 0.5g product 458.7g 452.4g 454.7g 449.9g 431.5g yield 91.2% 89.9% 90.4% 89.4% 85.8% HPLC purity 99.6% 99.5% 99.5% 99.4% 98.5% .

[0018] (Examples 6-7) The preparation methods of each embodiment are basically the same as those of Example 1, and the differences are shown in Table 2.

[0019] (Comparative Examples 1 to 2) The preparation methods of each comparative example are basically the same as those of Example 1, with the differences shown in Table 2.

[0020] Table 2 Example 1 Example 6 Example 7 Comparative Example 1 Comparative Example 2 organophosphine ligands Xantphos Xantphos Xantphos Triphenylphosphine Antphos Cobalt catalyst cobalt chloride cobalt bromide Cobalt acetylacetonate cobalt chloride cobalt chloride product 458.7g 456.2g 457.7g 396.8g 410.4g yield 91.2% 90.7% 91.0% 78.9% 81.6% HPLC purity 99.6% 99.7% 99.5% 98.1% 98.3%

[0021] In Table 2, the chemical name of Antphos is 4-(anthracite-9-yl)-3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxophosphanecyclopentadiene.

Claims

1. A method for preparing cresoltrazol trisiloxane, comprising a hydrosilylation reaction of 2-(2'-hydroxy-3'-methylallyl-5'-methylphenyl)benzotriazole and heptamethyltrisiloxane; characterized in that: The hydrosilylation reaction is carried out in the presence of an organophosphorus ligand and a cobalt catalyst.

2. The method for preparing cresoltrazol trisiloxane according to claim 1, characterized in that: The organophosphine ligand is 4,5-bisdiphenylphosphine-9,9-dimethyloxanthracene.

3. The method for preparing cresoltrazol trisiloxane according to claim 1 or 2, characterized in that: The cobalt catalyst is one of cobalt chloride, cobalt bromide, and cobalt acetylacetonate.

4. The method for preparing cresoltrazol trisiloxane according to claim 1 or 2, characterized in that: The weight ratio of the organophosphine ligand to the cobalt catalyst is 10:1 to 2:

1.

5. The method for preparing cresoltrazol trisiloxane according to claim 4, characterized in that: The weight ratio of the organophosphine ligand to the cobalt catalyst is 6:1 to 3:

1.

6. The method for preparing cresoltrazol trisiloxane according to claim 1 or 2, characterized in that: The total amount of the organophosphorus ligand and the cobalt catalyst is 0.1 to 10% of the weight of 2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole.

7. The method for preparing cresoltrazol trisiloxane according to claim 6, characterized in that: The total amount of the organophosphorus ligand and the cobalt catalyst is 0.5 to 2% of the weight of the 2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole.

8. The method for preparing cresoltrazol trisiloxane according to claim 1 or 2, characterized in that: The molar ratio of 2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole to heptamethyltrisiloxane is 1:1 to 1:

3.

9. The method for preparing cresoltrazol trisiloxane according to claim 8, characterized in that: The molar ratio of 2-(2'-hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole to heptamethyltrisiloxane is 1:1.1 to 1:1.

5.

10. The method for preparing cresoltrazol trisiloxane according to claim 1 or 2, characterized in that: The hydrosilylation reaction temperature is 40–100°C.

Citation Information

Patent Citations

  • Preparation method of cresol trozole trisiloxane

    CN120623220A

  • The invention relates to a 2-(2apos; -hydroxy-3apos,-hydroxy-3apos; -methallyl-5apos,-methallyl-5apos; preparation method of-methylphenyl) benzotriazole and preparation method of cresol trozole trisiloxane

    CN120757511A

  • Preparation method of cresol trozole trisiloxane

    CN121537427A